Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared a post on LinkedIn:
“The final sentence in this abstract could just as accurately conclude with ‘Given the limitations of this study, further investigation is warranted to identify the utility of surgery for octogenarian patients when SBRT is inherently safer in this population’.
Why? Because far too many patients over 80 have died within a few weeks of surgery for stage I NSCLC, including some of mine, driven by a ‘belief’ that surgery is the better treatment.
Including the many whose fatal complications aren’t even reported in this mansucript.”
Title: Wedge Resection vs Stereotactic Body Radiation Therapy for Stage 1 Non-Small Cell Lung Cancer in Octogenarians
Authors: Rolfy A Perez Holguin, William G Wong, Chan Shen, Matthew D Taylor, Michael F Reed, Pauline H Go
Read the Full Article.
Other articles featuring Drew Moghanaki on OncoDaily.